New study checks Long-Term safety of arthritis drug for PMR patients
NCT ID NCT06331312
First seen Nov 05, 2025 · Last updated May 16, 2026 · Updated 16 times
Summary
This study looks at the long-term safety of a drug called secukinumab for people with polymyalgia rheumatica (PMR), a condition that causes pain and stiffness. About 161 adults who finished a previous PMR study and had a relapse will take part. The goal is to track side effects over time, not to test if the drug works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POLYMYALGIA RHEUMATICA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Accurate Clinical Research Inc
San Antonio, Texas, 78229, United States
-
Advanced Rheumatology of Houston
Spring, Texas, 77382, United States
-
Arizona Arthritis and Rheumatology Associates PLLC
Avondale, Arizona, 85392, United States
-
Arthritis Center of North Georgia
Gainesville, Georgia, 30501, United States
-
Center for Rheumatology Research
West Hills, California, 91307, United States
-
Clinical Research Inst of MI
Saint Clair Shores, Michigan, 48081, United States
-
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
-
Kansas City Physician Partners
Kansas City, Missouri, 64111, United States
-
Klein and Associates
Hagerstown, Maryland, 21740, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Millennium Clinical Trials
Westlake Village, California, 91361, United States
-
Novartis Investigative Site
Parramatta, New South Wales, 2150, Australia
-
Novartis Investigative Site
Southport, Queensland, 4215, Australia
-
Novartis Investigative Site
Heidelberg Heights, Victoria, 3081, Australia
-
Novartis Investigative Site
Liège, 4000, Belgium
-
Novartis Investigative Site
Porto Alegre, Rio Grande do Sul, 90480-000, Brazil
-
Novartis Investigative Site
São Paulo, São Paulo, 04038-002, Brazil
-
Novartis Investigative Site
São Paulo, 01409-902, Brazil
-
Novartis Investigative Site
Québec, Quebec, G1V 3M7, Canada
-
Novartis Investigative Site
Santiago, Santiago Metropolitan, 7500571, Chile
-
Novartis Investigative Site
Santiago, Santiago Metropolitan, 8420383, Chile
-
Novartis Investigative Site
Viña del Mar, Valparaiso, 2531172, Chile
-
Novartis Investigative Site
Barranquilla, Atlántico, 080002, Colombia
-
Novartis Investigative Site
Barranquilla, Atlántico, 080020, Colombia
-
Novartis Investigative Site
Bogota, Cundinamarca, 110221, Colombia
-
Novartis Investigative Site
Cali, Valle del Cauca Department, 760042, Colombia
-
Novartis Investigative Site
Prague, Czech Republic, 140 00, Czechia
-
Novartis Investigative Site
Brno, 638 00, Czechia
-
Novartis Investigative Site
Hlučín, 748 01, Czechia
-
Novartis Investigative Site
Prague, 128 00, Czechia
-
Novartis Investigative Site
Prague, 140 00, Czechia
-
Novartis Investigative Site
Uherské Hradiště, 686 01, Czechia
-
Novartis Investigative Site
Zlín, 760 01, Czechia
-
Novartis Investigative Site
Esbjerg, 6700, Denmark
-
Novartis Investigative Site
Gandrup, 9362, Denmark
-
Novartis Investigative Site
Vejle, DK-7100, Denmark
-
Novartis Investigative Site
Toulon, Val De Marne, 83800, France
-
Novartis Investigative Site
Brest, 29200, France
-
Novartis Investigative Site
Cholet, 49325, France
-
Novartis Investigative Site
Colmar, 68024, France
-
Novartis Investigative Site
Dijon, 21000, France
-
Novartis Investigative Site
Le Mans, 72000, France
-
Novartis Investigative Site
Montpellier, 34295, France
-
Novartis Investigative Site
Nantes, 44093, France
-
Novartis Investigative Site
Reims, 51092, France
-
Novartis Investigative Site
Strasbourg, 67000, France
-
Novartis Investigative Site
Toulouse, 31059, France
-
Novartis Investigative Site
Quilmes, Buenos Aires, B1878GEG, Argentina
-
Novartis Investigative Site
Buenos Aires, C1055AAF, Argentina
-
Novartis Investigative Site
Freiburg im Breisgau, Baden-Wurttemberg, 79106, Germany
-
Novartis Investigative Site
Würzburg, Bavaria, 97080, Germany
-
Novartis Investigative Site
Berlin, 13125, Germany
-
Novartis Investigative Site
Berlin, 13353, Germany
-
Novartis Investigative Site
Herne, 44649, Germany
-
Novartis Investigative Site
Budapest, 1027, Hungary
-
Novartis Investigative Site
Szeged, 6725, Hungary
-
Novartis Investigative Site
Veszprém, 8200, Hungary
-
Novartis Investigative Site
Bolzano, BZ, 39100, Italy
-
Novartis Investigative Site
Milan, MI, 20100, Italy
-
Novartis Investigative Site
Perugia, PG, 06129, Italy
-
Novartis Investigative Site
Fukuoka, Fukuoka, 8140180, Japan
-
Novartis Investigative Site
Asahikawa, Hokkaido, 0708644, Japan
-
Novartis Investigative Site
Kita-gun, Kagawa-ken, 7610793, Japan
-
Novartis Investigative Site
Sagamihara, Kanagawa, 252-0392, Japan
-
Novartis Investigative Site
Yokohama, Kanagawa, 222-0036, Japan
-
Novartis Investigative Site
Nagano, Nagano, 3808582, Japan
-
Novartis Investigative Site
Kawachi-Nagano, Osaka, 5868521, Japan
-
Novartis Investigative Site
Bunkyo Ku, Tokyo, 1138431, Japan
-
Novartis Investigative Site
Fuchū, Tokyo, 1838524, Japan
-
Novartis Investigative Site
Ōme, Tokyo, 198-0042, Japan
-
Novartis Investigative Site
Chūō, Yamanashi, 409-3898, Japan
-
Novartis Investigative Site
Okayama, 700-8607, Japan
-
Novartis Investigative Site
Osaka, 5340021, Japan
-
Novartis Investigative Site
Guadalajara, Jalisco, 44650, Mexico
-
Novartis Investigative Site
Almelo, Overijssel, 7609 PP, Netherlands
-
Novartis Investigative Site
Rotterdam, South Holland, 3079 DZ, Netherlands
-
Novartis Investigative Site
Lublin, 20-607, Poland
-
Novartis Investigative Site
Warsaw, 02-118, Poland
-
Novartis Investigative Site
Warsaw, 02-665, Poland
-
Novartis Investigative Site
Cape Town, Western Cape, 7405, South Africa
-
Novartis Investigative Site
Cape Town, Western Cape, 7500, South Africa
-
Novartis Investigative Site
Sabadell, Barcelona, 08208, Spain
-
Novartis Investigative Site
Bilbao, Bizkaia, 48013, Spain
-
Novartis Investigative Site
A Coruña, 15006, Spain
-
Novartis Investigative Site
Madrid, 28009, Spain
-
Novartis Investigative Site
Seville, 41013, Spain
-
Novartis Investigative Site
Valencia, 46010, Spain
-
Novartis Investigative Site
Sankt Gallen, 9007, Switzerland
-
Novartis Investigative Site
Barnet, EN5 3DJ, United Kingdom
-
Novartis Investigative Site
Hull, HU3 2RW, United Kingdom
-
Novartis Investigative Site
Wolverhampton, WV10 0QP, United Kingdom
-
Orrin Troum MD and Medical Associates
Santa Monica, California, 90404, United States
-
Paramount Med Rsrch and Consult LLC
Middleburg Heights, Ohio, 44130, United States
-
Prolato Clinical Research Center
Houston, Texas, 77054, United States
-
Rheumatology Associates of South Florida
Boca Raton, Florida, 33486, United States
-
Sarasota Arthritis Res Ctr
Sarasota, Florida, 34239, United States
-
Sun Valley Arthritis Center Ltd
Peoria, Arizona, 85381, United States
-
UF Health Cancer Center
Gainesville, Florida, 32610, United States
-
West Broward Rheumatology Associates Inc
Tamarac, Florida, 33321, United States
Conditions
Explore the condition pages connected to this study.